Category: Abiomed Inc.
Abiomed's former director of investor relations, Susan Vissers Lisa, jumps ship for Boston Scientific's IR vice president role.
Susan Vissers Lisa, the former director of investor relations at Abiomed (NSDQ:ABMD), was named vice president of IR at Boston Scientific (NYSE:BSX).
Company officials at Abiomed discuss the company's Q2 2014 earnings results. Abiomed logged profits of $1.1 million, or 3¢ per share, on sales of $44.3 million for the 3 months ended Sept. 30.
Abiomed shares flirt with a 52-week high after the medical device company reports strong fiscal 2nd-quarter sales growth and beats Wall Street's earnings expectations.
Abiomed (NSDQ:ABMD) shares approached a 52-week high this morning after the medical device company reported fiscal 2nd-quarter sales growth of nearly 19% and beat Wall Street's earnings forecast.
Abiomed shares surge on Medicare move to maintain reimbursement rates for the Impella heart pump.
Shares of Abiomed (NSDQ:ABMD) surged nearly 10% today after news broke that Medicare will maintain the reimbursement rate for its flagship Impella heart pump.
Massachusetts medical device company Abiomed hands a $375,000 grant to Boston Children's Hospital to support its new heart health center.
MASSDEVICE ON CALL — Massachusetts-based medical device maker Abiomed (NSDQ:ABMD) announced a multi-year $375,000 grant donated to Boston Children's Hospital Heart Center, the newly minted cardiovascular care department of Boston Children's Hospital.
The funding will help support the Heart Center's efforts advance research and education initiatives in 3 main areas, Abiomed said:
Abiomed's explanation of a possible Medicare reimbursement change for its flagship Impella heart pump helps ease its recent share price slide.
Shares of Abiomed (NSDQ:ABMD) rebounded nearly 8% today after the medical device company sought to reassure investors about proposed changes to Medicare reimbursement for its flagship Impella heart pump.
A new Veterans Administration contract for Impella heart pumps could boost Abiomed's revenues by 20%.
Massachusetts-based Abiomed (NSDQ:ABMD) won a lucrative 5-year contract to provide its flagship Impella heart pumps to the Veterans Administration, a deal that could boost the medical device maker's revenue by 20%.